Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03371212 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 1, 2025 to Dec 1, 2035
    • Study completion date: Dec 1, 2026 to Dec 1, 2036
    v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary completion date: Sep 1, 2024 to Dec 1, 2025v9
  4. Primary completion date: May 1, 2024 to Sep 1, 2024v8
  5. Primary completion date: May 24, 2023 to May 1, 2024v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: May 24, 2021 to May 24, 2023v6
  2. Primary completion date changed from estimate of Dec 1, 2021 to May 24, 2021
    • Study completion date: Dec 1, 2024 to Dec 1, 2026
    v5
  3. Primary completion date: Dec 1, 2019 to Dec 1, 2021
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  4. Primary completion date: Jan 1, 2019 to Dec 1, 2019
    • Study completion date: Jan 1, 2024 to Dec 1, 2024
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study description shortened, about 9 words
    • Site details revised
    • Study title shortened, about 9 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to determine if the use of a modular dual mobility bearing is associated with clinically important increases in serum metal levels.
Trial Details
NCT Number NCT03371212
Lead Sponsor Rush University Medical Center
Collaborators: Zimmer Biomet
Conditions
(from sponsor)		 Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov